Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.31 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.31 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.31 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7527544 | 0.98 | LMNA (0.35) | LMNASLC22A6CACNA2D1CACNB3CACNA1C | |
| SCHEMBL4445540 | 0.80 | LMNA (0.44) | LMNAALDH1A1 | |
| SCHEMBL7536748 | 0.78 | LMNA (0.46) | LMNAALDH1A1 | |
| SCHEMBL4952556 | 0.77 | GPR84 (0.41) | LMNASLC22A6CACNA2D1CACNB3CACNA1C | |
| SCHEMBL5112958 | 0.75 | ALDH1A1 (0.58) | LMNASLC22A6ALDH1A1TDP1 | |
| SCHEMBL4654992 | 0.75 | ALDH1A1 (0.58) | LMNASLC22A6ALDH1A1TDP1 | |
| SCHEMBL5104868 | 0.75 | ALDH1A1 (0.58) | LMNASLC22A6ALDH1A1TDP1 | |
| SCHEMBL7820083 | 0.75 | SLC22A6 (0.33) | LMNASLC22A6CACNA2D1CACNB3CACNA1C | |
| Acetic Acid SCHEMBL2467469 | 0.74 | LMNA (0.38) | LMNAALDH1A1 | |
| SCHEMBL317762 | 0.73 | LMNA (0.61) | LMNASLC22A6ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090030093-A1 | METHOD FOR EMULSION POLYMERISATION OF OLEFINS | BASF AKTIENGESSELLSCHAFT (DE) | 2009-01-29 | — | — | US | disclosed |
| US-7417098-B2 | Method for emulsion polymerisation of olefins | BASF SE (DE) | 2008-08-26 | — | — | US | disclosed |
| US-20080182915-A1 | METHOD FOR EMULSION POLYMERISATION OF OLEFINS | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-31 | — | — | US | disclosed |
| EP-1636282-B1 | METHOD FOR THE PRODUCTION OF AN AQUEOUS POLYMER DISPERSION | BASF AG (DE) | 2007-05-02 | — | — | EP | disclosed |
| US-20070043163-A1 | Method for emulsion polymerisation of olefins | BASF AKTIENGESELLSCHAFT (DE) | 2007-02-22 | — | — | US | disclosed |
| EP-1196475-B1 | METHOD FOR THE PRODUCTION OF OLEFIN/CARBON MONOXIDE COPOLYMERS | BASF AG (DE) | 2005-07-20 | — | — | EP | disclosed |
| US-6670443-B1 | Feeding ethylene in pulses | BASF AKTIENGESELLSCHAFT (DE) | 2003-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080182915-A1 | METHOD FOR EMULSION POLYMERISATION OF OLEFINS | SQLE, PHOSPHO1, ALOX15 | LMNA 4276/4885SLC22A6 2599/4885CACNA2D1 3275/4885 |
| US-20070043163-A1 | Method for emulsion polymerisation of olefins | PHOSPHO1, SQLE, ALOX15 | LMNA 4462/4885SLC22A6 2460/4885CACNA2D1 3121/4885 |
| US-20090030093-A1 | METHOD FOR EMULSION POLYMERISATION OF OLEFINS | PHOSPHO1, SQLE, ALOX15 | LMNA 4462/4885SLC22A6 2460/4885CACNA2D1 3121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.